Patents Examined by Manuel Mendez
-
Patent number: 11373746Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject and insulin injection data is obtained. A first glycaemic risk measures is determined, where the first risk glycaemic risk measure is i) glucose level variability across the glucose measurements, (ii) a variability in fasting glucose levels calculated from the glucose measurements, (iii) a minimum observed glucose measurement in the plurality of glucose measurements (iv) rate of change in ISF, or (v) adherence values. A fasting blood glucose target function is computed based upon at least the first glycaemic risk measure thereby obtaining an updated target fasting blood glucose level that is between a minimum and maximum target fasting blood glucose level. The long acting insulin medicament dosage is adjusted based upon the updated target fasting blood glucose level.Type: GrantFiled: June 23, 2017Date of Patent: June 28, 2022Assignee: Novo Nordisk A/SInventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Pete Brockmeier
-
Patent number: 11369729Abstract: Methods and apparatuses for automatically switching different aspiration levels to an ocular probe are disclosed herein. The probe may be a phacoemulsification probe. A first aspiration level, supplied by a first pump, may be applied to the probe simultaneously with ultrasonic energy. A second aspiration level, supplied by a second pump, may be automatically switched from the first aspiration level. Control feed back of the pumps may be varied according to set thresholds.Type: GrantFiled: February 10, 2017Date of Patent: June 28, 2022Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Robert G. Raney, Michael J. Claus, James Gerg, Wayne S. Wong, David A. King, James W. Staggs, Fred Lee
-
Patent number: 11369728Abstract: Methods and apparatuses for automatically switching different aspiration levels to an ocular probe are disclosed herein. The probe may be a phacoemulsification probe. A first aspiration level, supplied by a first pump, may be applied to the probe simultaneously with ultrasonic energy. A second aspiration level, supplied by a second pump, may be automatically switched from the first aspiration level. Control feed back of the pumps may be varied according to set thresholds.Type: GrantFiled: February 10, 2017Date of Patent: June 28, 2022Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Robert G. Raney, Michael J. Claus, James Gerg, Wayne S. Wong, David A. King, James W. Staggs, Fred Lee
-
Patent number: 11364145Abstract: Methods and systems for automatically pulsing different aspiration levels to an ocular probe are disclosed. The probe may be a phacoemulsification probe. A first aspiration level, supplied by a first pump, may be applied to the probe simultaneously with ultrasonic energy. A second aspiration level, supplied by a second pump, may be automatically switched from the first aspiration level, and applied to the probe in a pulsed manner.Type: GrantFiled: December 11, 2015Date of Patent: June 21, 2022Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Robert G. Raney, Michael Claus, James Gerg, Wayne S. Wong, David A. King, James W. Staggs, Fred Lee
-
Patent number: 11357942Abstract: An insertion guide facilitates insertion of an endotracheal tube (ETT) into the trachea of a patient instead of the esophagus of the patient. The ETT includes an elongated, somewhat flexible, generally hollow tube and the insertion guide includes an elongated, solid and relatively rigid shaft that is configured to be positioned within the hollow tube of the ETT. The shaft is provided with a radiused portion and/or an angled portion adjacent a distal end of the insertion guide that protrudes outwardly beyond a distal end of the ETT. The radiused portion and/or the angled portion of the shaft facilitate insertion of the distal end of the ETT past the epiglottis and into the trachea of the patient instead of into the esophagus of the patient.Type: GrantFiled: September 30, 2019Date of Patent: June 14, 2022Assignee: D R Burton Healthcare, LLCInventors: Jason Annis, Gregory Y. Lau
-
Patent number: 11357920Abstract: Data collection devices for attachment to injection devices are disclosed. In one embodiment, the data collection device includes: a body attachable to a dial member of the injection device, a sensor arrangement comprising a sensor and a scale, and a processor. The sensor is configured to detect a rotation of the body relative to a trigger of the injection device. The processor is configured to detect a rotation of the body relative to the trigger. One of the sensor and the scale is arranged in or on the body and wherein the other one of the sensor and the scale is located on the trigger or is rotationally lockable to the trigger configured to detect a rotation of the body relative to the trigger.Type: GrantFiled: December 5, 2017Date of Patent: June 14, 2022Assignee: SanofiInventors: Maurice Toporek, Michael Jugl, Günther Sendatzki, Oliver Charles Gazeley, Prasannah Nanayakkara, Aidan Michael O'Hare, Robert Veasey, David Aubrey Plumptre
-
Patent number: 11350862Abstract: Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.Type: GrantFiled: September 1, 2021Date of Patent: June 7, 2022Assignee: DexCom, Inc.Inventors: Jason Halac, John Charles Barry, Becky L. Clark, Chris W. Dring, John Michael Gray, Kris Elliot Higley, Jeff Jackson, David A. Keller, Ted Tang Lee, Jason Mitchell, Kenneth Pirondini, David Rego, Ryan Everett Schoonmaker, Peter C. Simpson, Craig Thomas Gadd, Kyle Thomas Stewart, John Stanley Hayes
-
Patent number: 11350886Abstract: Infusion devices and related medical devices, patient data management systems, and methods are provided for monitoring a physiological condition of a patient. An exemplary infusion device includes an actuation arrangement operable to deliver fluid to a user, a communications interface to receive measurement data indicative of a physiological condition of the user, a sensing arrangement to obtain contextual measurement data, and a control system coupled to the actuation arrangement, the communications interface and the sensing arrangement to determine a command for autonomously operating the actuation arrangement in a manner that is influenced by the measurement data and the contextual measurement data and autonomously operate the actuation arrangement in accordance with the command to deliver the fluid to the user.Type: GrantFiled: March 22, 2018Date of Patent: June 7, 2022Assignee: Medtronic MiniMed, Inc.Inventors: Huzefa F. Neemuchwala, Pratik Agrawal, Benyamin Grosman, Anirban Roy, Patrick E. Weydt, Louis J. Lintereur, Ali Dianaty, Yuxiang Zhong, Chantal M. McMahon
-
Patent number: 11355237Abstract: A system may include a data processor and a memory storing instructions. The instructions may result in operations when executed by the data processor. The operations may include determining, based on location data from a positioning system, a presence of a cartridge at a location. The cartridge may include a substance. A quantity of the substance may be determined based on content data from a content meter at the location. Diversion of the substance may be detected based on the cartridge being present at the location and/or the quantity of the substance. Related methods and articles of manufacture, including apparatuses and computer program products, are also disclosed.Type: GrantFiled: November 25, 2019Date of Patent: June 7, 2022Assignee: CareFusion 303, Inc.Inventor: Timothy W. Vanderveen
-
Patent number: 11338097Abstract: An active self-locking type syringe includes a barrel, needle hub, plunger assembly, plunger protection cover, needle cap, needle tube, needle point protection sleeve, spring, guiding limit assemblies, initial clamping assemblies and a trigger ring plug. In an initial state, the trigger ring plug is located in a trigger cavity and is not in contact with the trigger parts or is in contact with the trigger parts but not enough to separate the initial clamping assemblies, the inner wall of the trigger ring plug and the needle hub are sealed, and the outer wall of the trigger ring plug and the inner wall of the barrel are sealed. In the above structure, the trigger ring plug arranged in the trigger cavity is triggered from the interior of the barrel close to a patient end, and the needle point protection sleeve is released.Type: GrantFiled: December 11, 2018Date of Patent: May 24, 2022Assignee: Promisemed Hangzhou Meditech Co., Ltd.Inventor: Chaoyu Hu
-
Patent number: 11337725Abstract: A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece. The device and method cut the fibrous structures under the skin that cause cellulite at an angle substantially parallel to the surface of the skin and replace these structures with a non-cellulite forming structure by deploying a highly fibrous mesh through a single needle hole to create a highly fibrous layer directly or through wound healing processes.Type: GrantFiled: October 25, 2019Date of Patent: May 24, 2022Assignee: Ulthera, Inc.Inventors: Robert L. Clark, III, James E. Chomas, Adnan I. Merchant, Ben F. Brian, III
-
Patent number: 11324889Abstract: Exemplary embodiments may address the problem of missing blood glucose concentration readings from a glucose monitor that transmits blood glucose concentration readings over a wireless connection due to problems with the wireless connection. In the exemplary embodiments, an automated insulin delivery (AID) device uses an estimate in place of a missing blood glucose concentration reading in determining a predicted future blood glucose concentration reading for a user. Thus, the AID device is able to operate normally in generating insulin delivery settings despite not receiving a current blood glucose concentration reading for a current cycle. There is no need to suspend delivery of insulin to the user due to the missing blood glucose concentration reading.Type: GrantFiled: February 14, 2020Date of Patent: May 10, 2022Assignee: INSULET CORPORATIONInventors: Yibin Zheng, Joon Bok Lee, Ashutosh Zade, Jason O'Connor
-
Patent number: 11318260Abstract: A device for delivery of medicament is presented that has an elongated housing, a container mounted within the housing and adapted to contain liquid medicament, a stopper slidably arranged within said container, and a delivery mechanism comprising a resilient member, a plunger assembly having one end connected to the stopper and a second end being operably connected to the resilient member, a rotatable latch for releasably retaining the plunger assembly in a first position where the resilient member has an accumulated energy, where rotation of the latch releases the plunger assembly such that the accumulated energy is transferred to the plunger assembly for driving the stopper within the container whereby the medicament within said container is delivered to an injection site. After delivery of the medicament a rotator having a hard stop feature aligns with a rib on the protective shield to prevent retraction of the protective shield.Type: GrantFiled: August 22, 2019Date of Patent: May 3, 2022Assignee: SHL MEDICAL AGInventors: Antonio Bendek, Lucio Giambattista
-
Patent number: 11298461Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).Type: GrantFiled: June 8, 2018Date of Patent: April 12, 2022Assignee: Novo Nordisk A/SInventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Morten Lind Jensen, Pete Brockmeier
-
Patent number: 11298445Abstract: A breast pump milk flow rate sensor system and apparatus for accurately assessing both a flow rate and amount of milk expressed during a pumping session is provided. The breast pump milk flow rate sensor system and apparatus may be contained within a breast pump.Type: GrantFiled: January 9, 2019Date of Patent: April 12, 2022Assignee: Moxxly, LLCInventors: Santhi Analytis, Wisit Jirattigalachote, Jacob Kurzrock
-
Patent number: 11291778Abstract: The present disclosure provides a liquid constant temperature heating apparatus, an infusion device and a formula milk preparation device. The liquid constant temperature heating apparatus includes: a heating portion, the heating portion having a heating chamber, and the heating chamber having a liquid inlet and a liquid outlet; a liquid inlet pipe, the liquid inlet pipe being connected with the liquid inlet of the heating portion; a liquid outlet pipe, the liquid outlet pipe being connected with the liquid outlet of the heating portion; a temperature sensor, the temperature sensor being arranged on the liquid outlet pipe and in communication with the heating portion; and a controller, which is in signal connection with the temperature sensor by a signal and configured to control heating of the heating portion according to a measurement result of the temperature sensor.Type: GrantFiled: April 27, 2018Date of Patent: April 5, 2022Assignee: BOE TECHNOLOGY GROUP CO., LTD.Inventor: Zhenglong Li
-
Patent number: 11291769Abstract: Closed-loop systems and methods are described herein for regulating a flow of medication being intermittently infused to a patient based on one or more vital signs. The dosage rate of the medication can be adjusted periodically as needed to ensure the patient's vital sign remains with a target range. Various safeguards can be used to ensure the safety and efficacy of the closed-loop systems and methods.Type: GrantFiled: July 1, 2021Date of Patent: April 5, 2022Assignee: Perceptive Medical Inc.Inventor: Joseph Rinehart
-
Patent number: 11291794Abstract: The present disclosure generally relates to systems and methods for delivery of therapeutic gas to patients, using techniques to compensate for disruptions in breathing gas flow measurement, such as when breathing gas flow measurement is unavailable or unreliable. Such techniques include using historical breathing gas flow rate data, such as moving average flow rates, moving median flow rates and/or flow waveforms. At least some of these techniques can be used to ensure that interruption in therapeutic gas delivery is minimized or eliminated.Type: GrantFiled: October 10, 2019Date of Patent: April 5, 2022Assignee: Mallinckrodt Pharmaceuticals Ireland LimitedInventors: Jaron M. Acker, Craig R. Tolmie
-
Patent number: 11284918Abstract: A cannula sleeve for a surgical trocar assembly. The cannula sleeve includes a hollow shaft, at least a portion of which is made of a rigid material, and a seal at the distal end of the hollow shaft, the seal being movable between a first open position and a second closed position. The shaft defines a proximal end, a distal end, a periphery, and a longitudinal axis. The shaft further includes a channel at the periphery substantially parallel to the longitudinal axis, the channel being in communication with the hollow shaft.Type: GrantFiled: February 18, 2019Date of Patent: March 29, 2022Assignee: Cilag GmbH InlernationalInventors: David B. Griffith, Sean P. Conlon, William B. Weisenburgh, II, Christopher J. Hess, Kempton K. Carroll, II
-
Patent number: 11278671Abstract: An infusion pump is configured to provide one or more context cues to a user while the user programs the infusion pump to deliver an infusion therapy. In some embodiments, the infusion pump includes a display configured to display a keypad and to receive input from a user, a processor in communication with the display, and a memory in communication with the processor. The memory stores instructions that cause a keypad sequence monitor to receive context parameters, the context parameters corresponding to a drug selection, a drug concentration selection, or a clinical care area in which the drug is to be infused. The keypad sequence monitor accesses a drug library using the context parameter to determine a valid parameter range corresponding to a range of values between lower and upper soft limit values stored in the drug library.Type: GrantFiled: December 4, 2019Date of Patent: March 22, 2022Assignee: ICU Medical, Inc.Inventors: Dirceu Galvao Cavendish, Jr., Diego Andres Kaplan, James Cudney, Kerin Leigh Klagges-Kingsbury